125 related articles for article (PubMed ID: 1496594)
1. Studies of immunosuppression with quadruple regimen treatment (cyclosporine, mizoribine, prednisolone, and antilymphocyte globulin) in cadaveric and living-related donor renal allotransplantation.
Sato K; Matsuzawa K; Tadokoro F; Kakita A; Okubo M; Kumano K; Mashimo K; Endo T; Watanabe K
Transplant Proc; 1992 Aug; 24(4):1383-5. PubMed ID: 1496594
[No Abstract] [Full Text] [Related]
2. Immunosuppressive treatment of primary cadaveric renal transplant patients receiving kidneys from non-heart beating donors.
Ohshima S; Fujita T; Ono Y; Kinukawa T; Katoh N; Matsuura O
Artif Organs; 1996 Oct; 20(10):1130-6. PubMed ID: 8896734
[TBL] [Abstract][Full Text] [Related]
3. Studies on immunosuppression with low-dose cyclosporine combined with mizoribine in experimental and clinical cadaveric renal allotransplantation.
Osakabe T; Uchida H; Masaki Y; Yokota K; Sato K; Nakayama Y; Ohkubo M; Kumano K; Endo T; Watanabe K
Transplant Proc; 1989 Feb; 21(1 Pt 2):1598-600. PubMed ID: 2652520
[No Abstract] [Full Text] [Related]
4. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
Guttmann RD; Flemming C
Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
[TBL] [Abstract][Full Text] [Related]
5. Five years' experience with quadruple sequential immunosuppression.
Fischbach M; Wolff P; Tongio MM; Boudjema K; Christmann D; Steib A; Sauvage P; Desprez P; Mengus L; Simeoni U
Transplant Proc; 1994 Feb; 26(1):17. PubMed ID: 8108924
[No Abstract] [Full Text] [Related]
6. Quadruple immunosuppression in renal allografts--the Auckland experience.
Verran D; Munn S; Doak P; Williams L; Collins J; Lee W
N Z Med J; 1991 Dec; 104(925):517-8. PubMed ID: 1758662
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression without prophylactic antilymphocyte preparations.
Pfaff WW; Patton PR; Howard RJ; Brunson ME; Ramos EL; Fennell RS; Peterson JC; Scornik JC
Clin Transpl; 1992; ():237-48. PubMed ID: 1306702
[TBL] [Abstract][Full Text] [Related]
8. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy.
Giral M; Taddei C; Nguyen JM; Dantal J; Hourmant M; Cantarovich D; Blancho G; Ancelet D; Soulillou JP
Clin Transpl; 1996; ():257-64. PubMed ID: 9286575
[TBL] [Abstract][Full Text] [Related]
9. Collaborative Transplant Study--10-year report.
Opelz G
Transplant Proc; 1992 Dec; 24(6):2342-55. PubMed ID: 1465795
[No Abstract] [Full Text] [Related]
10. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants.
Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG
Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888
[No Abstract] [Full Text] [Related]
11. Comparison of antilymphocyte globulin and continuous i.v. cyclosporine A as induction immunosuppression for cadaver kidney transplants: a prospective randomized study.
Belitsky P; MacDonald AS; Cohen AD; Crocker J; Hirsch D; Jindal K; Lawen J
Transplant Proc; 1991 Feb; 23(1 Pt 2):999-1000. PubMed ID: 1989359
[No Abstract] [Full Text] [Related]
12. Antilymphocyte globulin in cadaveric renal transplantation--a controlled trial.
Jakobsen A; Sødal G; Flatmark A; Thorsby E
Scand J Urol Nephrol Suppl; 1977; (42):94-6. PubMed ID: 356233
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with antilymphocyte-globulin in cadaveric kidney transplantation.
Ahlmen J; Storm B; Brynger H; Sandberg L; Gelin LE
Scand J Urol Nephrol Suppl; 1977; (42):90-3. PubMed ID: 356232
[TBL] [Abstract][Full Text] [Related]
14. Prevention of rejection and graft loss with an aggressive quadruple immunosuppressive therapy regimen in children and adolescents.
Conley SB; al-Uzri A; So S; Salvatierra O
Transplantation; 1994 Feb; 57(4):540-4. PubMed ID: 8116038
[TBL] [Abstract][Full Text] [Related]
15. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
16. Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era.
Hariharan S; Alexander JW; Schroeder TJ; First MR
Clin Transplant; 1996 Apr; 10(2):186-90. PubMed ID: 8664516
[TBL] [Abstract][Full Text] [Related]
17. Cadaveric kidney transplantation under prophylactic polyclonal antibody immunosuppression with anti-lymphoblast globulin versus anti-thymocyte globulin.
Indudhara R; Novick AC; Hodge E; Goormastic M; Papajcik D; Mastroianni B; Cook D
Urology; 1996 Jun; 47(6):807-12. PubMed ID: 8677568
[TBL] [Abstract][Full Text] [Related]
18. Low-dose cyclosporine and antithymocyte globulin improve renal allograft survival in highly sensitized patients.
Palmer A; Bewick M; Welsh K; Snowden S; Parsons V; Taube D
Transplant Proc; 1988 Jun; 20(3 Suppl 3):198-200. PubMed ID: 3291241
[No Abstract] [Full Text] [Related]
19. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
[TBL] [Abstract][Full Text] [Related]
20. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
Schulz T; Kapischke M; Busing M
Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
